Cancer Mortality in Common Mental Disorders: A 10-year Retrospective Cohort Study

Overview

Journal Soc Psychiatry Psychiatr Epidemiol

Specialties Psychiatry
Public Health
Social Sciences

Date 2022 Nov 17

PMID 36394636

Authors

Federico Chierzi

Elisa Stivanello

Muriel Assunta Musti

Vincenza Perlangeli

Paolo Marzaroli

Francesco De Rossi

Paolo Pandolfi

Alessio Saponaro

Luigi Grassi

Martino Belvederi Murri

Angelo Fioritti

Domenico Berardi

Marco Menchetti

Affiliations

Soon will be listed here.

Abstract

Purpose: Individuals with Common Mental Disorders (CMDs) may have a higher cancer mortality. The purpose of this study was to examine cancer-related mortality among patients with CMDs and verify which cancer types are predominantly involved.

Methods: We used the Regional Mental Health Registry of the Emilia-Romagna region, in Northern Italy to identify patients aged ≥ 18 years who received an ICD 9-CM diagnosis of CMDs (i.e., depressive and neurotic disorders) over a 10 year period (2008-2017). Information on cause of death was retrieved from the Regional Cause of Death Registry. Comparisons were made with data from the regional population without CMDs.

Results: Among 101,487 patients suffering from CMDs (55.7% depression; 44.3% neurotic disorders), 3,087 (37.8%) died from neoplasms. The total standardized mortality ratio (SMR) was 1.82 (95% CI 1.78-1.86) while the SMR for all neoplasms was 2.08 (95% CI 2.01-2.16). Individuals of both genders, with both depressive and neurotic disorders had a higher risk of death from almost all cancers compared with the regional population.

Conclusion: Patients with CMDs have considerably higher cancer mortality risk than the general population. Higher mortality was observed for a broad range of cancers associated with different aetiologies. It is imperative to promote cancer awareness, prevention and treatment for people with CMDs.

Citing Articles

Colorectal cancer mortality in persons with severe mental illness: a scoping review with meta-analyses of observational studies.

Pop P, Larsen G, Thomsen M, Johansen C, Zachariae R, Rafn B Acta Oncol. 2025; 64:358-373.

PMID: 40045534 PMC: 11905152. DOI: 10.2340/1651-226X.2025.42260.

Socioeconomic Burden of Psychiatric Cancer Patients: A Narrative Review.

Wieckiewicz G, Weber S, Florczyk I, Gorczyca P Cancers (Basel). 2024; 16(6).

PMID: 38539443 PMC: 10969503. DOI: 10.3390/cancers16061108.

Depressive Symptoms, Socioeconomic Position, and Mortality in Older People Living With and Beyond Cancer.

Miller N, Fisher A, Frank P, Lally P, Steptoe A Psychosom Med. 2024; 86(6):523-530.

PMID: 38497671 PMC: 11230845. DOI: 10.1097/PSY.0000000000001294.

References

Koyanagi A, Kohler-Forsberg O, Benros M, Munk Laursen T, Haro J, Nordentoft M . Mortality in unipolar depression preceding and following chronic somatic diseases. Acta Psychiatr Scand. 2018; 138(6):500-508. DOI: 10.1111/acps.12899. View

Berardi D, Stivanello E, Chierzi F, Musti M, Perlangeli V, Pandolfi P . Mortality in mental health patients of the Emilia-Romagna region of Italy: A registry-based study. Psychiatry Res. 2021; 296:113702. DOI: 10.1016/j.psychres.2020.113702. View

Bortolato B, Hyphantis T, Valpione S, Perini G, Maes M, Morris G . Depression in cancer: The many biobehavioral pathways driving tumor progression. Cancer Treat Rev. 2016; 52:58-70. DOI: 10.1016/j.ctrv.2016.11.004. View

Grassi L, Riba M . Cancer and severe mental illness: Bi-directional problems and potential solutions. Psychooncology. 2020; 29(10):1445-1451. DOI: 10.1002/pon.5534. View

Steel Z, Marnane C, Iranpour C, Chey T, Jackson J, Patel V . The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013. Int J Epidemiol. 2014; 43(2):476-93. PMC: 3997379. DOI: 10.1093/ije/dyu038. View

Zhu J, Fang F, Sjolander A, Fall K, Adami H, Valdimarsdottir U . First-onset mental disorders after cancer diagnosis and cancer-specific mortality: a nationwide cohort study. Ann Oncol. 2017; 28(8):1964-1969. DOI: 10.1093/annonc/mdx265. View

Prasad S, Eggener S, Lipsitz S, Irwin M, Ganz P, Hu J . Effect of depression on diagnosis, treatment, and mortality of men with clinically localized prostate cancer. J Clin Oncol. 2014; 32(23):2471-8. PMC: 4121505. DOI: 10.1200/JCO.2013.51.1048. View

Rantanen A, Kallio M, Korkeila J, Kautiainen H, Korhonen P . Relationship of non-melancholic and melancholic depressive symptoms with all-cause mortality: A prospective study in a primary care population. J Psychosom Res. 2020; 133:110107. DOI: 10.1016/j.jpsychores.2020.110107. View

Formoso G, Marino M, Guberti M, Grilli R . End-of-life care in cancer patients: how much drug therapy and how much palliative care? Record linkage study in Northern Italy. BMJ Open. 2022; 12(5):e057437. PMC: 9083387. DOI: 10.1136/bmjopen-2021-057437. View

10.

Das-Munshi J, Schofield P, Bhavsar V, Chang C, Dewey M, Morgan C . Ethnic density and other neighbourhood associations for mortality in severe mental illness: a retrospective cohort study with multi-level analysis from an urbanised and ethnically diverse location in the UK. Lancet Psychiatry. 2019; 6(6):506-517. PMC: 6551347. DOI: 10.1016/S2215-0366(19)30126-9. View

11.

Whiteford H, Degenhardt L, Rehm J, Baxter A, Ferrari A, Erskine H . Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013; 382(9904):1575-86. DOI: 10.1016/S0140-6736(13)61611-6. View

12.

Cattaruzza M, Maisonneuve P, Boyle P . Epidemiology of laryngeal cancer. Eur J Cancer B Oral Oncol. 1996; 32B(5):293-305. DOI: 10.1016/0964-1955(96)00002-4. View

13.

Moise N, Khodneva Y, Jannat-Khah D, Richman J, Davidson K, Kronish I . Observational study of the differential impact of time-varying depressive symptoms on all-cause and cause-specific mortality by health status in community-dwelling adults: the REGARDS study. BMJ Open. 2018; 8(1):e017385. PMC: 5780736. DOI: 10.1136/bmjopen-2017-017385. View

14.

Goodwin G . The overlap between anxiety, depression, and obsessive-compulsive disorder. Dialogues Clin Neurosci. 2015; 17(3):249-60. PMC: 4610610. View

15.

Otonari J, Ikezaki H, Furusyo N, Sudo N . Do neuroticism and extraversion personality traits influence disease-specific risk factors for mortality from cancer and cardiovascular disease in a Japanese population?. J Psychosom Res. 2021; 144:110422. DOI: 10.1016/j.jpsychores.2021.110422. View

16.

Goodwin J, Zhang D, Ostir G . Effect of depression on diagnosis, treatment, and survival of older women with breast cancer. J Am Geriatr Soc. 2003; 52(1):106-11. PMC: 1853251. DOI: 10.1111/j.1532-5415.2004.52018.x. View

17.

Sharpe C, Collet J, Belzile E, Hanley J, Boivin J . The effects of tricyclic antidepressants on breast cancer risk. Br J Cancer. 2002; 86(1):92-7. PMC: 2746543. DOI: 10.1038/sj.bjc.6600013. View

18.

Walker J, Magill N, Mulick A, Symeonides S, Gourley C, Toynbee M . Different independent associations of depression and anxiety with survival in patients with cancer. J Psychosom Res. 2020; 138:110218. PMC: 7614809. DOI: 10.1016/j.jpsychores.2020.110218. View

19.

Solmi M, Firth J, Miola A, Fornaro M, Frison E, Fusar-Poli P . Disparities in cancer screening in people with mental illness across the world versus the general population: prevalence and comparative meta-analysis including 4 717 839 people. Lancet Psychiatry. 2019; 7(1):52-63. DOI: 10.1016/S2215-0366(19)30414-6. View

20.

Grassi L, Stivanello E, Belvederi Murri M, Perlangeli V, Pandolfi P, Carnevali F . Mortality from cancer in people with severe mental disorders in Emilia Romagna Region, Italy. Psychooncology. 2021; 30(12):2039-2051. PMC: 9290959. DOI: 10.1002/pon.5805. View